ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,795Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 336

$715K Total Retail Price of All Prescriptions

Rank: 86 out of 336

465 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 12,044 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 586 487 1 3
SIMVASTATIN 560 530 2 5
POTASSIUM CHLORIDE 458 410 3 9
AMLODIPINE BESYLATE 445 408 4 1
PRAVASTATIN SODIUM 445 383 4 10
GABAPENTIN 329 277 6 11
ZOLPIDEM TARTRATE 314 249 7 18
LOSARTAN-HYDROCHLOROTHIAZIDE 312 292 8 45
ATORVASTATIN CALCIUM 306 286 9 14
FUROSEMIDE 284 237 10 4
LEVOTHYROXINE SODIUM 262 251 11 7
METOPROLOL SUCCINATE 261 223 12 15
TRAMADOL HCL 242 205 13 20
LOSARTAN POTASSIUM 241 209 14 22
LISINOPRIL 224 198 15 6
MELOXICAM 215 191 16 19
METFORMIN HCL 204 173 17 8
ATENOLOL 191 178 18 26
HYDROCHLOROTHIAZIDE 173 152 19 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 142 20 23
EVISTA 154 146 21 106
HYDROCODONE-ACETAMINOPHEN 154 106 S3 21 2
TRIAMTERENE-HCTZ 152 131 23 35
CRESTOR 140 123 24 25
ALLOPURINOL 134 130 25 30
CITALOPRAM HBR 131 122 26 21
KLOR-CON M20 121 88 27 51
DIOVAN 120 105 28 31
CLOPIDOGREL 118 110 29 28
CARVEDILOL 116 113 30 13
PANTOPRAZOLE SODIUM 106 105 31 40
SYNTHROID 104 103 32 43
NEXIUM 102 94 33 24
DONEPEZIL HCL 101 101 34 27
TAMSULOSIN HCL 100 91 35 38
ESTRADIOL 98 96 R 36 129
GLYBURIDE-METFORMIN HCL 96 95 R 37 78
TRAZODONE HCL 92 53 38 46
PLAVIX 90 80 39 37
ALENDRONATE SODIUM 88 88 40 54
ROPINIROLE HCL 86 76 41 98
LIPITOR 85 75 42 62
FLUOXETINE HCL 85 62 42 81
WELCHOL 83 63 44 195
AMLODIPINE BESYLATE-BENAZEPRIL 79 76 45 47
FLUTICASONE PROPIONATE 77 65 46 49
WARFARIN SODIUM 77 75 46 17
CYMBALTA 76 56 48 52
AMIODARONE HCL 73 64 49 117
PROPRANOLOL HCL 71 71 50 101
RANITIDINE HCL 70 70 51 36
SERTRALINE HCL 70 59 51 33
ONGLYZA 69 67 53 165
DIOVAN HCT 69 52 53 41
BENICAR HCT 69 69 53 132
AMITRIPTYLINE HCL 66 32 R 56 57
NABUMETONE 66 60 56 159
VENLAFAXINE HCL ER 66 45 56 100
NAMENDA 65 65 59 39
CYCLOBENZAPRINE HCL 65 44 R 59 65
JANUVIA 61 61 61 67
LANTUS SOLOSTAR 59 35 62 124
BENAZEPRIL HCL 58 45 63 59
CLONIDINE HCL 58 30 63 32
FINASTERIDE 54 54 65 156
FENOFIBRATE 53 53 66 72
BYSTOLIC 52 41 67 79
GEMFIBROZIL 51 28 68 115
SINGULAIR 50 50 69 85
BENICAR 50 47 69 112
HYDROXYCHLOROQUINE SULFATE 50 47 69 176
DILTIAZEM ER 50 34 69 138
RAMIPRIL 50 50 69 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.